Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Alfresa Holdings ( (JP:2784) ).
Alfresa Holdings Corporation announced a revision to its performance-linked stock compensation plan as it transitions to a company with an audit and supervisory committee structure. This change aims to align the interests of directors and executive officers with shareholders by using a Board Incentive Plan trust to grant shares based on performance. The revision is subject to approval at the upcoming shareholders meeting and includes additional contributions to the trust, enhancing transparency and independence in remuneration decisions.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2120.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation operates in the healthcare industry, focusing on pharmaceutical distribution and manufacturing. The company provides a range of healthcare products and services, primarily targeting the Japanese market.
Average Trading Volume: 511,221
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen414.9B
For an in-depth examination of 2784 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue